%D9%83%D8%AB%D8%B1%D8%A9_%D9%83%D8%B1%D9%8A%D8%A7%D8%AA_%D8%A7%D9%84%D8%AF%D9%85_%D8%A7%D9%84%D8%AD%D9%85%D8%B1Category:PolycythemiasPolyglobuliePolycythemiaPolicitemiaPol%C3%BCts%C3%BCteemiaPolysytemiaPolyglobuliePolaic%C3%ADotaemachtPolicitemijaPolisitemiaPolicitemia%E5%A4%9A%E8%A1%80%E7%97%87Eritrocitoz%C4%97%D0%9F%D0%BE%D0%BB%D0%B8%D1%86%D0%B8%D1%82%D0%B5%D0%BC%D0%B8%D1%98%D0%B0%E0%B4%AA%E0%B5%8B%E0%B4%B3%E0%B4%BF%E0%B4%B8%E0%B5%88%E0%B4%A4%E0%B5%8D%E0%B4%A4%E0%B5%80%E0%B4%AE%E0%B4%BF%E0%B4%AFPolycythemieNadkrwisto%C5%9B%C4%87PoliglobuliaPolicitemijaPolycytemi%E0%B9%80%E0%B8%A1%E0%B9%87%E0%B8%94%E0%B9%80%E0%B8%A5%E0%B8%B7%E0%B8%AD%E0%B8%94%E0%B9%81%E0%B8%94%E0%B8%87%E0%B8%A1%E0%B8%B2%E0%B8%81PolisitemiQ933716
about
Gabriele SalvatoresAzacitidine and Sonidegib or Decitabine in Treating Patients With Myeloid MalignanciesInfluence of Umbilical Cord Clamping Time in the NewbornDose-Finding Study of Pacritinib in Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis Previously Treated With RuxolitinibTreatment of High Altitude Polycythemia by AcetazolamideCyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic SyndromeSafety and Efficacy of Momelotinib in Subjects With Polycythemia Vera or Essential ThrombocythemiaTissue Banking Study - Polycythemia Vera or Essential Thrombocythemia (PV & ET) PatientsMomelotinib Versus Ruxolitinib in Subjects With MyelofibrosisOpen Label Ruxolitinib (INCB018424) in Patients With Myelofibrosis and Post Polycythemia Vera/Essential Thrombocythemia MyelofibrosisA Study of the Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential ThrombocythaemiaSecondary Cancers in Myeloproliferative Neoplasms (MPN-K Study)KRT-232 in Subjects With PMF, Post-PV MF, or Post-ET MF Who Have Failed a JAK InhibitorFludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without CancerTacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic CancerA Phase 1/2 Study of Oral SB1518 in Subjects With Chronic Idiopathic MyelofibrosisPD-1 Inhibition in Advanced Myeloproliferative NeoplasmsINC424 for Patients With Primary Myelofibrosis, Post Polycythemia Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis.Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative NeoplasmsSafety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MFAlternative Dosing Strategy of Ruxolitinib in Patients With MyelofibrosisSafety Study Evaluating Twice-Daily Administration of Momelotinib in Primary Myelofibrosis or Post-Polycythemia Vera or Post-Essential Thrombocythemia MyelofibrosisStudy With SAR302503 in Patients With Polycythemia Vera or Essential ThrombocythemiaStudy of the Effects of Commercial Air Travel on the LungsRuxolitinib (INCB018424) in Subjects With Primary Myelofibrosis, Post Essential Thrombocythemia-myelofibrosis and Post Polycythemia Vera-myelofibrosisLBH589 (Panobinostat) for the Treatment of MyelofibrosisOpen Label Study to Evaluate the Activity of Imetelstat in Patients With Essential Thrombocythemia or Polycythemia VeraExtension Study Evaluating the Long Term Safety and Efficacy Study of CYT387 in Primary Myelofibrosis (PMF) or Post-polycythemia Vera (PV) or Post-essential Thrombocythemia (ET)Selinexor in Myelofibrosis Refractory or Intolerant to JAK1/2 InhibitorsExtended Access of Momelotinib in Adults With MyelofibrosisInfection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell TransplantAzacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaMPN-RC 118 AVID200 in MyelofibrosisThe NUTRIENT Trial (NUTRitional Intervention Among myEloproliferative Neoplasms): Feasibility PhaseAn Efficacy and Safety Trial of Fedratinib in Subjects With DIPSS, Intermediate or High-Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis and Previously Treated With RuxolitinibKRT-232 Compared to Ruxolitinib in Patients With Phlebotomy-Dependent Polycythemia VeraPhase 1 Study of Digoxin for Congenital Polycythemia Due to Up-Regulated Hypoxia SensingPulmonary Hypertension, Hypoxia and Sickle Cell DiseaseAssess the Safety, Tolerability Oral PU-H71 in Subjects Taking RuxolitinibAnti-TGF-beta Therapy in Patients With Myelofibrosis
P1050
Familial erythrocytosis arising from a gain-of-function mutation in the HIF2A gene of the oxygen sensing pathway.Anabolic steroids, acute myocardial infarction and polycythemia: a case report and review of the literature.Normal and pathological erythropoiesis in adults: from gene regulation to targeted treatment conceptsFetal stroke and cerebrovascular disease: Advances in understanding from lenticulostriate and venous imaging, alloimmune thrombocytopaenia and monochorionic twins
P921
Q55465-943e3953-4a34-8aed-f719-3888e66582adQ61894499-53EC0C85-21C7-4191-89B0-D402B0051F9FQ61902303-D058318A-E9FD-448C-9A0C-23286A91F358Q61908774-077009E1-8679-4806-851A-339CA772C8F1Q61921550-4606FB87-2212-4FD6-97EB-F62DA4B71535Q61924544-C80D2716-B114-4E42-850E-2F006FB54088Q61969415-EC714F03-4936-4C6C-9F74-4082EC49DA30Q61975323-2DC8A17A-09C2-486B-B8A3-299A5BE141BDQ61975403-B3149C50-5A86-484D-BD9C-D52BF621CBB6Q61979326-7F743D7B-D583-4F60-A3DA-7C4B11728361Q61980959-A8ABD871-02FA-4A02-980A-4AE7B8202ADDQ62034506-E3E4846C-5A26-41B5-B54E-304B4B3B0608Q62062253-E0603D41-D95A-4759-B7C2-B563C895191CQ62105038-2E4C604D-DA51-4281-BA06-71AEB521AA81Q62110098-D85F68EF-A5B1-4B0B-9747-FEBA1652ABB0Q63062220-E5DF7A62-BF14-4947-A57D-E1F58AC279B0Q63229537-9C204BA1-447B-417E-B885-99204FB648A1Q63319936-A611A7DE-4A41-40B9-AC34-B4E0AFE8649CQ63320463-DFF2BE14-D105-47C3-B43B-E3BA0E9E8377Q63321625-6C793302-7B2D-4524-B78C-4B7BEC7D2AFCQ63321638-843D1A57-9A3F-4F75-A1D4-319FC19D4156Q63321780-BA212772-5928-4698-AE1A-D2375AE729A1Q63322214-31474B5C-A935-4DBC-8DF7-0E72BD397BDFQ63322313-056DAF25-77D7-40E2-A086-DED9D1E1B38EQ63335474-76C0A17C-C3CD-444B-96F8-0517FB888BA8Q63338573-2937B673-E644-42B2-BC45-A3D49F9D40F1Q63340079-10D6DAB5-3ACF-48C2-9974-E9E4FB4DF576Q63340642-B5A1C49F-0E49-484D-98AA-ABDF89200F44Q63393521-764C7CB0-08E9-4918-8A3B-49A17071CAFBQ63401017-CEE1EA1A-DBCB-40F0-A549-3ECAF1909107Q63572918-6EF4F858-4250-47B0-BE13-AD9A0D02876DQ63577998-5A0B65AE-491C-4536-B22A-319CC6749617Q63580663-E2DE5BAB-F6BA-43FD-A73B-EA54F37C8819Q63587655-A93ED616-577C-429A-BF94-BD4A4AA318AEQ63594153-A786F52B-6D2A-434B-AD2F-BD87C4D5F544Q63599122-4D45E272-4E51-4330-8E73-131867B212B9Q63613489-F65C92BA-C1A8-4DCA-B503-1F8CDE091E45Q63804919-E44CDDA9-CAA0-4DFC-A59B-C0C7B85EDB92Q63805315-0082B47F-6DC7-40D3-AE3F-98D2CF139197Q63814063-0471112F-C68E-4EE6-AF3D-817402404E88
P1050
description
Human disease
@en
Krankheit
@de
Organismoan odoleko globulu gorrien kopurua handitzean datzan asaldua
@eu
Penyakit Manusia
@id
aumento del volume percentuale occupato dai globuli rossi nel sangue
@it
Болест крви
@sr
مرض يصيب الإنسان
@ar
രക്തത്തിൽ ചുവന്ന രക്തകോശങ്ങളുടെ അളവ് വർദ്ധിച്ചിരിക്കുന്ന അവസ്ഥയാണ് പോളിസൈത്തീമിയ
@ml
name
Eritremija
@lt
Polaicíotaemacht
@ga
Policitemija
@hr
Policitemija
@sr
Polisitemi
@tr
Polisitemia
@id
Polycythemie
@nl
Polyglobulie
@de
Polysytemia
@fi
Polütsüteemia
@et
type
label
Eritremija
@lt
Polaicíotaemacht
@ga
Policitemija
@hr
Policitemija
@sr
Polisitemi
@tr
Polisitemia
@id
Polycythemie
@nl
Polyglobulie
@de
Polysytemia
@fi
Polütsüteemia
@et
altLabel
Eritrocitosi
@it
Polycythemia
@en
erythrocythemia
@en
poliglobulia
@it
polycythémie
@cs
polyglobuli
@nn
紅血球增多症
@zh
红细胞增多
@zh-hans
红细胞增多症
@zh
血球增多
@zh
prefLabel
Eritremija
@lt
Polaicíotaemacht
@ga
Policitemija
@hr
Policitemija
@sr
Polisitemi
@tr
Polisitemia
@id
Polycythemie
@nl
Polyglobulie
@de
Polysytemia
@fi
Polütsüteemia
@et
P279
P2888
P2892
P486
P508
P6366
P646
P672
P1417
science/erythrocythemia
science/polycythemia
P1550
P1748
P1995
P2892
P31
P3219
polyglobulies
P3417
Polycythemia